PIP3 Regulation as Promising Targeted Therapy of Mast-Cell-Mediated Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|34|3815-3822

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.34, 2011-11, pp. : 3815-3822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 347-354

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1323-1329

Bentham Science Publishers

Access to resources Recommend Favorite

Mast cells can revert dexamethasone-mediated down-regulation of stem cell factor

By Brito J.M.   Mermelstein C.S.   Tempone A.J.   Borojevic R.  

European Journal of Pharmacology, Vol. 414, Iss. 1, 2001-02 ,pp. : 105-112

Elsevier

Access to resources Recommend Favorite

Targeted therapy combos promising for breast cancer

By  

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Targeting CD44 in mast cell regulation

By Tanaka Satoshi  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite